The Global Fund is coordinating the rollout of PlusLife MiniDock Ultra near point-of-care TB test systems across 13 countries, supported by $50 million from the Children’s Investment Fund Foundation. The effort targets faster, more accessible TB testing in settings where traditional lab workflows can delay diagnosis. The announcement ties diagnostic scaling to implementation in multiple geographies, with partners working to deploy systems and operationalize testing networks in participating countries. For developers and diagnostics firms, the program signals continued emphasis on point-of-need molecular testing infrastructure as health agencies look to reduce time-to-result and improve case finding.